Literature DB >> 19079676

Fasting plasma glucose levels are related to bone mineral density in postmenopausal women with primary hyperparathyroidism.

Itoko Hisa, Hiroshi Kaji, Yoshifumi Inoue, Toshitsugu Sugimoto, Kazuo Chihara.   

Abstract

How glucose levels affect bone in patients with primary hyperparathyroidism is unknown, although the prevalence of impaired glucose metabolism is higher in patients with primary hyperparathyroidism. The present study was performed to examine the relationships between fasting plasma glucose (FPG) and various indices in 93 postmenopausal women with primary hyperparathyroidism. Bone mineral density (BMD) and body composition were measured by dual-energy Xray absorptiometry. Body weight, body mass index (BMI), fat mass and % fat were positively related to FPG. Serum levels of calcium and parathyroid hormone (PTH) as well as bone metabolic indices were not related to FPG and immunoreactive insulin levels. As for BMD, FPG was positively related to the Z scores of BMD at the lumbar spine and femoral neck, although it was not significantly related to the Z-score of BMD at the radius. On the other hand, immunoreactive insulin levels were not significantly related to BMD parameters at any sites. In multiple regression analysis, FPG was significantly related to BMD (Z score) at the lumbar spine and femoral neck, when body weight, BMI, immunoreactive insulin, PTH, and bone resorption indices were considered; however, these relationships at the lumbar spine were not significant when fat mass was considered. In conclusion, the present study indicated that FPG levels were positively related to BMD at the lumbar spine and femoral neck in postmenopausal women with primary hyperparathyroidism.

Entities:  

Keywords:  Primary hyperparathyroidism; body composition; bone mineral density; glucose

Year:  2008        PMID: 19079676      PMCID: PMC2596330     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  23 in total

1.  Relationship between body composition and bone mass in women.

Authors:  S Khosla; E J Atkinson; B L Riggs; L J Melton
Journal:  J Bone Miner Res       Date:  1996-06       Impact factor: 6.741

2.  The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  H Kaji; R Nomura; M Yamauchi; K Chihara; T Sugimoto
Journal:  Horm Metab Res       Date:  2006-06       Impact factor: 2.936

Review 3.  Anabolic actions of parathyroid hormone on bone.

Authors:  D W Dempster; F Cosman; M Parisien; V Shen; R Lindsay
Journal:  Endocr Rev       Date:  1993-12       Impact factor: 19.871

4.  Association of the -112A>C polymorphism of the uncoupling protein 1 gene with insulin resistance in Japanese individuals with type 2 diabetes.

Authors:  Keiko Fukuyama; Takeshi Ohara; Yushi Hirota; Kengo Maeda; Shin-ichi Kuno; Masako Zenibayashi; Tetsuya Teranishi; Kunichi Kouyama; Eiichi Maeda; Norihiro Sakamoto; Masato Kasuga
Journal:  Biochem Biophys Res Commun       Date:  2005-12-05       Impact factor: 3.575

5.  Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.

Authors:  D Nakaoka; T Sugimoto; H Kaji; M Kanzawa; S Yano; M Yamauchi; T Sugishita; K Chihara
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

Review 6.  Coincident diabetes mellitus and primary hyperparathyroidism.

Authors:  W H Taylor; A A Khaleeli
Journal:  Diabetes Metab Res Rev       Date:  2001 May-Jun       Impact factor: 4.876

7.  Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy.

Authors:  A A Khaleeli; J N Johnson; W H Taylor
Journal:  Diabetes Metab Res Rev       Date:  2007-01       Impact factor: 4.876

8.  Improved peripheral cortical bone geometry after surgical treatment of primary hyperparathyroidism in postmenopausal women.

Authors:  Hiroshi Kaji; Mika Yamauchi; Rikako Nomura; Toshitsugu Sugimoto
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

9.  Analysis of factors affecting increase in bone mineral density at lumbar spine by bisphosphonate treatment in postmenopausal osteoporosis.

Authors:  Hiroshi Kaji; Itoko Hisa; Yoshifumi Inoue; Junko Naito; Toshitsugu Sugimoto; Masato Kasuga
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

10.  Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism.

Authors:  Yoshifumi Inoue; Hiroshi Kaji; Itoko Hisa; Takako Tobimatsu; Junko Naito; Mei-Fway Iu; Toshitsugu Sugimoto; Kazuo Chihara
Journal:  Endocr J       Date:  2008-01-10       Impact factor: 2.349

View more
  5 in total

1.  Effect of supplementation of drumstick (Moringa oleifera) and amaranth (Amaranthus tricolor) leaves powder on antioxidant profile and oxidative status among postmenopausal women.

Authors:  Shalini Kushwaha; Paramjit Chawla; Anita Kochhar
Journal:  J Food Sci Technol       Date:  2012-10-05       Impact factor: 2.701

2.  The effects of sodium tanshinone IIa sulfonate pretreatment on high glucose-induced expression of fractalkine and apoptosis in human umbilical vein endothelial cells.

Authors:  Fa-Qi Li; De-Kang Zeng; Chao-Li Jia; Ping Zhou; Ling Yin; Bin Zhang; Fang Liu; Qing Zhu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Parathyroid Hormone Reprograms Osteoblast Metabolism.

Authors:  Ryan C Riddle
Journal:  J Bone Miner Res       Date:  2015-11       Impact factor: 6.741

4.  Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women.

Authors:  Kyong-Chol Kim; Dong-Hyuk Shin; Sei-Young Lee; Jee-Aee Im; Duk-Chul Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

5.  The developmental effects of isoflavone aglycone administration on early chick embryos.

Authors:  Yasuhiko Kawakami; Kenichi Saito; Yasuhiko Itoh
Journal:  Interdiscip Toxicol       Date:  2019-10-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.